Literature DB >> 27271339

A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.

Tiago A Mestre1,2, Andreea Manole3, Heather MacDonald4, Sheila Riazi5, Natalia Kraeva5, Michael G Hanna3, Anthony E Lang1, Roope Männikkö6, Grace Yoon7,8.   

Abstract

Episodic ataxia type 1 (EA1) is an autosomal dominant channelopathy caused by mutations in KCNA1, which encodes the voltage-gated potassium channel, Kv1.1. Eleven members of an EA family were evaluated with molecular and functional studies. A novel c.746T>G (p.Phe249Cys) missense mutation of KCNA1 segregated in the family members with episodic ataxia, myokymia, and malignant hyperthermia susceptibility. No mutations were found in the known malignant hyperthermia genes RYR1 or CACNA1S. The Phe249Cys-Kv1.1 channels did not show any currents upon functional expression, confirming a pathogenic role of the mutation. Malignant hyperthermia may be a presentation of KCNA1 mutations, which has significant implications for the clinical care of these patients and illustrates the phenotypic heterogeneity of KCNA1 mutations.

Entities:  

Keywords:  Episodic ataxia; KCNA1; Malignant hyperthermia

Mesh:

Substances:

Year:  2016        PMID: 27271339     DOI: 10.1007/s10048-016-0486-0

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  13 in total

1.  Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.

Authors:  Catherine A Brownstein; Alan H Beggs; Lance Rodan; Jiahai Shi; Meghan C Towne; Renee Pelletier; Siqi Cao; Paul A Rosenberg; David K Urion; Jonathan Picker; Wen-Hann Tan; Pankaj B Agrawal
Journal:  Neurogenetics       Date:  2015-09-22       Impact factor: 2.660

2.  Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves.

Authors:  L Zhou; C L Zhang; A Messing; S Y Chiu
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

3.  Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency.

Authors:  P Zerr; J P Adelman; J Maylie
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

Review 4.  Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Authors:  J C Jen; T D Graves; E J Hess; M G Hanna; R C Griggs; R W Baloh
Journal:  Brain       Date:  2007-06-15       Impact factor: 13.501

5.  Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.

Authors:  Marilyn Green Larach; Gerald A Gronert; Gregory C Allen; Barbara W Brandom; Erik B Lehman
Journal:  Anesth Analg       Date:  2010-02-01       Impact factor: 5.108

6.  A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.

Authors:  Michelle K Demos; Vincenzo Macri; Kevin Farrell; Tanya N Nelson; Kristine Chapman; Eric Accili; Linlea Armstrong
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

7.  Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.

Authors:  D L Browne; S T Gancher; J G Nutt; E R Brunt; E A Smith; P Kramer; M Litt
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

8.  Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.

Authors:  Maria C D'Adamo; Constanze Gallenmüller; Ilenio Servettini; Elisabeth Hartl; Stephen J Tucker; Larissa Arning; Saskia Biskup; Alessandro Grottesi; Luca Guglielmi; Paola Imbrici; Pia Bernasconi; Giuseppe Di Giovanni; Fabio Franciolini; Luigi Catacuzzeno; Mauro Pessia; Thomas Klopstock
Journal:  Front Physiol       Date:  2015-01-15       Impact factor: 4.566

9.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

10.  Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.

Authors:  Susan Elizabeth Tomlinson; Sanjeev Rajakulendran; Stella Veronica Tan; Tracey Dawn Graves; Doris-Eva Bamiou; Robyn W Labrum; David Burke; Carolyn M Sue; Paola Giunti; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-24       Impact factor: 13.654

View more
  11 in total

1.  Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants.

Authors:  Senthilkumar Sadhasivam; Barbara W Brandom; Richard A Henker; John J McAuliffe
Journal:  Pharmacogenomics       Date:  2019-09       Impact factor: 2.533

2.  A novel mutation in SLC1A3 causes episodic ataxia.

Authors:  Kazuhiro Iwama; Aya Iwata; Masaaki Shiina; Satomi Mitsuhashi; Satoko Miyatake; Atsushi Takata; Noriko Miyake; Kazuhiro Ogata; Shuichi Ito; Takeshi Mizuguchi; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2017-12-05       Impact factor: 3.172

Review 3.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

4.  Mutations underlying Episodic Ataxia type-1 antagonize Kv1.1 RNA editing.

Authors:  Elizabeth A Ferrick-Kiddie; Joshua J C Rosenthal; Gregory D Ayers; Ronald B Emeson
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

Review 5.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

Review 6.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 7.  Paroxysmal motor disorders: expanding phenotypes lead to coalescing genotypes.

Authors:  Laura Zima; Sophia Ceulemans; Gail Reiner; Serena Galosi; Dillon Chen; Michelle Sahagian; Richard H Haas; Keith Hyland; Jennifer Friedman
Journal:  Ann Clin Transl Neurol       Date:  2018-07-17       Impact factor: 4.511

Review 8.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

Review 9.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

Authors:  Maria Cristina D'Adamo; Antonella Liantonio; Jean-Francois Rolland; Mauro Pessia; Paola Imbrici
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

10.  Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.

Authors:  Antonio Castellano; Aurora Pujol; Edgard Verdura; Carme Fons; Agatha Schlüter; Montserrat Ruiz; Stéphane Fourcade; Carlos Casasnovas
Journal:  J Med Genet       Date:  2019-10-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.